The World Conference on Lung Cancer in Sydney is coming closer, October 27-30, 2013. A very exciting program has been established by the program committee and particularly the two Conference Presidents, Drs. Michael Boyer and Kwun Fong. Please note that the deadline for abstract is June 21, 2013 and we hope as many members as possible will submit abstracts. Please refer to www.iaslc.org for more information. The IASLC would like to draw your attention to the special travel awards offered to the patient’s advocates (see below).
A significant step towards implementation of personalized medicine for lung cancer patients is the recent publication of the CAP/IASLC/AMP Guidelines for Molecular Testing. The IASLC is proud to be a part of this development, which should improve patient care and secure the many patients with lung cancer the most optimal therapy based on standardized and validated molecular tests. The IASLC is currently putting considerable effort into implementing these guidelines in clinical practice.
The IASLC is seeking volunteer members to serve in our committees, and this can be done through a self-nomination process (see below).
Beginning in June, the IASLC will have the membership voting on new members for the Board of Directors and Officers. The ballot is in the process of being finalized and will be posted on our web site: www.iaslc.org very soon.
A new and improved IASLC member registration has been launched (see below) and should make the membership registration easier.
The IASLC is in the process of producing a new “Multidisciplinary Textbook in Thoracic Malignancies” under the Editorship of Drs Harvey Pass, Giorgio V. Scagliotti and David Ball. Some chapters will be completed and presented at the World Conference in Sydney, and the textbook is planned to be publically available at ASCO Annual Meeting in 2014.
Furthermore, IASLC is currently working on an ALK-Diagnostic Atlas, which will be finished and distributed at the World Conference in Sydney.
The IASLC has played a crucial role in developing the WHO/IASLC histopathological classification of lung tumors and other intra-thoracic malignant tumors. The multidisciplinary IASLC/WHO pathology panel is now planning for a new classification, which tentatively will be published in early 2015. The project is coordinated from IASLC by Drs William Travis, Elisabeth Brambilla and Andrew Nicholson.
For our Asian members, IASLC is proud to announce that the first Asian IASLC Office has opened in Hong-Kong and our contact person, Vengie Lau (email@example.com), will be presented in the next Newsletter.
With best regards,
Fred R. Hirsch, MD, PhD, Editor IASLC Newsletter
15th World Conference on Lung Cancer – October 27 – 30, 2013
More information please go to www.iaslc.org
Applications Open for WCLC 2013 Advocacy Travel Awards
The International Association for the Study of Lung Cancer (IASLC) invites patient advocates to apply for the organization’s Advocacy Travel Awards. The IASLC will offer travel awards to a limited number of patient advocates to participate in the World Conference on Lung Cancer Oct. 27-30, 2013 in Sydney, Australia. Awardees receive free conference registration, up to four nights’ accommodations, a free IASLC Membership and a cash award for 1,000 AUD. The IASLC will award up to five travel awards. All applicants must be current members, but Advocates can join the IASLC for just US$50. Fewer than five may be awarded. Full details regarding the application process and eligibility selection are available on the WCLC Website: http://wclc.iaslc.org/scientific-program/scholarships.html#AdvocacyAwards. The submission deadline is June 21, 2013.
Committee Self-Nomination Process Open
The IASLC seeks a highly competent and active pool of members to serve as volunteers on its organizational committees. IASLC Committees contribute significantly to the effective operation and development of IASLC programs. Committees open for nominations are provided below. Typically committee membership represents a broad geographic spectrum and a multidisciplinary perspective. Committee members are recommended by the President with approval of the Board of Directors. Potential committee members come from numerous sources including via the self-nomination process. If you are an active member of IASLC, with interest to serve on a committee, please read the full self-nomination description and complete the online form: http://www.iaslc.org/about-iaslc/iaslc-committees/. The deadline for self-nominations is May 20, 2013 for term of service on a Committee to run from 2013-2017.
Member Feedback is requested – IASLC 2013 Membership Survey
Thank you for being a member of IASLC. IASLC is seeking feedback on Membership benefits, programs, and services and has distributed a survey to all 2012 and 2013 members. The survey must be taken by a unique link which was emailed to all members. If you did not receive the link, please expect a reminder email by April 15th, or email firstname.lastname@example.org to have the link resent directly. The anonymous survey can be completed within 5 minutes and we appreciate as much detailed feedback as you wish.
Update Regarding 2013 Member Renewal
IASLC has launched a new online member registration system for 2013 and all members will have received an email with renewal instructions by January 31st. If you do not receive the email, you may pay dues directly at www.iaslc.org/membership, or please email email@example.com with any questions. The new system is designed to be easier for you to renew your membership with IASLC, while also providing important updated and complete information for IASLC. It is increasingly important that are able to contact you in the event your professional location changes or if your institution’s email security prevents our communications from reaching you, so we have updated certain required fields during registration. To renew now, please visit the following link: www.iaslc.org/membership.
Members will be able to renew instantly online via credit card, or you can create a custom invoice after confirming your contact details. Also, in order to improve the services we can provide you, we are currently renovating the existing member website and it will be temporarily unavailable. The 2012 Online Member Directory is still available to members at a private website address. If you need to have the Online Member Directory link emailed to you again, please email firstname.lastname@example.org. Once the new site, features, and 2013 Member Directory are available, we will notify members directly. NOTE to American Express users: Due to certain individual security settings that may be activated on your card, you may need to confirm directly with Amex that the transaction with IASLC is intended. Thank you for your membership in IASLC.
The Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors has been a joint effort between the College of American Pathologists (CAP), the IALSC and the Association for Molecular Pathology (AMP). The Guidelines are released on the IASLC and JTO websites early April. A webcast with the lead authors and co-chairs of the Guideline will be given in late April. Please watch for emails or monitor the IASLC website.
The IASLC is currently writing an ALK-Diagnostic Atlas, which will be finished and made available at the World Conference in Sidney. The Atlas will discuss issues related to testing for ALK gene rearrangement by different methods. It will contain summary tables, publication references and particularly images for ALK-FISH, IHC and PCR. It is hope that the Atlas will be helpful for pathology laboratories conducting ALK testing as well as used by physicians involved in patients with ALK-positive tumors. Below is a photo of the participants in the IASLC-ALK workshop, who recently met in
Sorrento, Italy. The project is coordinated by Drs. Ming Tsao, Yasushi Yatabe and Fred
Front left: Yasushi Yatabe, Marileila Varella-Garcia, Elisabeth Brambilla, Sylvia Lantuejoul, Rania Gaspo, Jin-Haeng Chung
Behind left: Akahiko Yoshida, Ignacio Wistuba, Fred R. Hirsch, Ming Tsao, Erik Thunnissen, Lukas Bubendorf, Keith Kerr.
IASLC 40th Anniversary Professor Heine H. Hansen Fellowship
As we embark on the next 40 years of the International Association for the Study of Lung Cancer, we pause to celebrate the past 40 years. The IASLC Board of Directors commemorates this notable time in the IASLC history by a 40th Anniversary Campaign to raise money for an additional fellowship in order to strengthen our education of the next generation lung cancer investigators. This fellowship will be named in Professor Heine H. Hansen’s honor. Professor Hansen was instrumental in the development of the IASLC. He was Congress President of the 2nd World Conference on Lung Cancer in Copenhagen in 1980. He served on the Board of Directors from 1985 to 1994 and served as the President from 1988-1991. Prof. Hansen was the first Executive Director of the IASLC (1991-2001) and was also the founder of the first IASLC journal Lung Cancer in 1985. He was a leader in developing international guidelines for the staging and treatment of small cell lung cancer and arranged many international workshops in this field. He received the IASLC Merit Award in 1997 and became the first Honorary Member in 2003. The IASLC fellowships benefit young researchers with the intention of encouraging innovative research in lung cancer prevention and translational medicine worldwide. Board members have made significant contributions to kick off this campaign. Please show your commitment to the IASLC 40th Anniversary Campaign by contributing to the Professor Heine H. Hansen Fellowship.
Heine H. Hansen, M.D., Ph.D. (1938-2011)
Commitment Amount: USD 1,000 500 100 50 Other __________
Send payments to: IASLC
13100 E. Colfax Ave Unit 10
Aurora, CO 80011
New IASLC Fellowship/Young Investigator Award winners 2013 - 2015
IASLC Web-based Education Programs
NOW AVAILABLE FROM THE IASLC WEBINAR SERIES:
Please visit www.iaslc.org for more details
JTO is now available as an iPad app, and can be downloaded from the App Store.
Starting with September, each issue will be available within the app the same day it is mailed and posted at jto.org. The first few issues will be free, but soon access will berestricted to members and paid subscribers. The same log in used for jto.org will be used to sign into the app when that feature is enabled. If you haven’t registered for a user name and password, you can do that any time at jto.org.
The app includes every page of the journal in a format optimized for reading on an iPad. Users can pinch and zoom to increase the size of figures and tables, scroll through the issue with the “quick view” feature, link directly from the table of contents to articles, and email articles to colleagues. Since the issue is downloaded in its entirety, the journal can be read later even if the iPad is in “airplane” mode or no connectivity is available. Issues can be saved on the iPad, or archived after reading and downloaded again at any time, as long as the user is still an IASLC member or paid subscriber. Notifications can be enabled to provide updates when a new issue is available.
We hope you will download and use JTO on your iPad. All of the features that make JTO so valuable to your practice are included, but now you can take issues with you whenever you have your iPad.
Upcoming IASLC Workshops/Meetings 2012- 2015
15th World Conference on Lung Cancer
October 27-30, 2013
Location: Sydney, Australia
More information: email@example.com
AACR- IASLC meeting on “Biology of Lung Cancer”
San Diego, CA
More information: firstname.lastname@example.org
14th Targeted Therapy Lung Cancer Meeting
Santa Monica, CA
More information: email@example.com
ELCC – European Lung Cancer Conference
LalCa- Latin American Lung Cancer Conference
Chicago Multidisciplinary Thoracic Oncology
October 31 – November 2, 2014
More information: firstname.lastname@example.org
APLCC- Asian Pacific lung Cancer Conference
16th World Conference on Lung Cancer
September 6-10, 2015
Location: Denver, Colorado, USA
More information: email@example.com
Non – IASLC Events:
Lung Cancer Clinical Trials:
Challenges & Opportunities in the Genomic Era
Friday, May 31, 2013 • 10:55 AM - 12:30 PM
The Hyatt Regency McCormick Place
Space is limited - Register early
This luncheon meeting presents a unique opportunity for medical professionals and
advocates to collaborate on shaping the future of lung cancer clinical trials by boosting
Attendees will engage in an interactive conversation on how we can work together to
swiftly overcome barriers to trial accrual.
Expert-led discussions will cover topics including:
- Challenges and solutions to boosting clinical trial accrual
- Innovative clinical trial designs and protocols
- Opportunities to bring trials to nonacademic medical centers and practices
- Developing and prioritizing an agenda for action
The University of Wisconsin School of Medicine and Public Health designates this live activity for a maximum of 1.5 AMA PRA
Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.12
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council of
Continuing Medical Education through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health
and the National Lung Cancer Partnership. The University of Wisconsin School of Medicine and Public Health is accredited by the
ACCME to provide continuing medical education for physicians.
Not an official event of the 2013 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or The Conquer Cancer Foundation.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - Chicago, ILOctober 14 2016Chicago, IL
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - Philadelphia, PAOctober 21 2016Philadelphia, PA
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - San FranciscoNovember 4 2016San Francisco, CA